Covid-fighting drug from S.F. biotech fizzles in late-stage trial
March 03, 2021 at 13:59 PM EST
Enrollment in the NIH trial was stopped, but other studies of the drug are continuing, the companies said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|